Dev

Molecular mechanisms of Parkinson pathology spread and potential therapeutic interventions Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

Protein quality control and Disease Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

Knowledge transfer in the field of redox biology for development of advanced molecular instruments in neurodegenerative diseases – the signature of transcription factor Nrf2 for diagnostic and treatment, REDBRAIN Investments > €500k Romania Alzheimer’s disease & other dementias|Neurodegenerative disease in…

Transgenic mice with elevated basal level of calcium ions in neurons as a model of agedinduced neurodegeneration of sporadic Alzheimer’s disease Investments > €500k Poland Alzheimer’s disease & other dementias 2016    

Regulatory mechanisms of dopamine synthesis; towards a therapeutic correction of catecholamine neurotransmiter deficiencies Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

Towards Alzheimer’s disease pre-dementia intervention: Meeting-point of diagnostics, genetics, and individual risk estimates Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

MOLECULAR MECHANISMS IN DELIRIUM AND DEMENTIA: IDENTIFICATION OF POTENTIAL THERAPEUTIC TARGETS Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

New biomarkers for early detection of Alzheimer’s disease Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Identifying genetic risk of dementia: from gene discovery to clinical implications Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

The Norwegian Cognitive impairment After STroke (COAST) study Investments > €500k Norway Alzheimer’s disease & other dementias 2016